Disease dilemmas

Disease. At some point, we all have to face it.

Incredible innovations in medical research are enabling us to live longer than ever before; but as we live longer, disease can seem inevitable. Whether fighting for ourselves or our loved ones, we face this fight time and again.

Like Brian, a husband, father, and grandfather with Parkinson’s disease.

Like Kathren, a newlywed and new mother diagnosed with pancreatic cancer.

Like Ashleigh, a scientist with an autoimmune disease.

Like George, a friend with multiple sclerosis.

It affects us all.

To support our family, friends and ourselves, we turn to medical research. How then, do you decide who you should support? With over 5,000 disease-related charities in Australia, it’s an impossible choice.

At Garvan, our genomics research can help them all.

The Garvan Institute brings together the brightest minds and cutting-edge technology to accelerate discovery. Our researchers have made significant advances in genome, epigenome, protein and cell analysis technology. We have revealed causes and treatments for diseases including diabetes, osteoporosis, cancer, immune deficiency and autoimmunity.

Today, Garvan’s mission builds on those advances, harnessing all the information encoded in our genome, from DNA to complex organ systems, to better diagnose, treat, predict and prevent disease.

At Garvan, the patient is at the heart of everything we do. Through our research programs and novel clinical trials, our clinician-scientists and community engagement, we are providing patients like Hosam answers to questions, opening new treatments avenues when all others had been exhausted, and providing hope. Hope that better diagnosis and treatments lie within reach.

“That’s what the beauty about the Garvan Institute is. They’re all about trying to find an option for you based on what the genes are telling you, rather than the type of cancer that you’ve got. Effectively, they were using a cancer drug that they used on skin cancers that they found shared the same genetic properties as my cancer. Garvan has given me so much hope" - Hosam.

Supporting Garvan’s research is supporting transformative science into over 50 of the most prevalent diseases today; from multiple sclerosis, brain cancer, and autoimmune disease to type 1 diabetes, Parkinson’s disease, kidney disease, and breast cancer. It is supporting the millions of Australians that live with a disease who look to medical research for a brighter future.